Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Ex-Pfizer staffers slap back at accusations they stole trade secrets for new Eli Lilly partner
4 years ago
Novartis' Sandoz settles with Novo Nordisk for 2024 launch of third Victoza generic
4 years ago
Law
Blasting Russia’s Ukraine invasion, Roche ships more meds and diagnostics to war-torn country
4 years ago
Amid inspection and recall woes, Aurobindo to shut down NJ site in April
4 years ago
Manufacturing
FDA approved? Yes, but quite a few pharmas leave out the messy details on accelerated approval
4 years ago
Schumer pledges vote on $35 insulin caps next month as other pricing reforms remain on hold for now
4 years ago
Law
Generic drug industry calls on FTC to dig into monopsony power among buyers, PBMs
4 years ago
Law
A look into the 340B explosion of growth as Gilead and J&J join more than a dozen peers setting their own terms
4 years ago
As branded drug sales surge, analysts predict China market will remain 'very attractive'
4 years ago
China
Teva reaches $100M settlement with Rhode Island for decade of anti-narcotic drugs and $21M cash
4 years ago
Serum Institute lands another vaccine collaboration, pushing business beyond the pandemic
4 years ago
Manufacturing
MarketingRx roundup: HHS’ vaccination ‘We Can’ campaign blanketed US; Moderna takes top PR honors
4 years ago
Marketing
Hunt for Russian oligarch’s billions leads to biotech activist investor Alex Denner’s fund — report
4 years ago
People
Big Pharma ad spending edges toward $7B with Sanofi, Regeneron and Novo Nordisk leading the way
4 years ago
R&D
Marketing
Novartis takes next step in Russia, halting new trials and enrollment as Big Pharma responds to Ukraine invasion
4 years ago
With latest Keytruda OK, Merck edges into GlaxoSmithKline’s (small) PD-1 turf
4 years ago
FDA+
Pfizer scores an 'A' on gender and racial pay equity report, while Biogen flunks
4 years ago
Covid vaccine patent landscape heats up as Pfizer's partner sues Arbutus and Genevant
4 years ago
Coronavirus
Law
Klick Health readies for 25th anniversary, tapping new talent and expanding practices
4 years ago
Marketing
'Wait, what?' First TV ad for AbbVie’s Vuity presbyopia eye drops highlights common surprised reaction
4 years ago
Marketing
Lonza inks deal with first customer at recently-expanded China manufacturing site
4 years ago
Manufacturing
After acquisitions and new deals, Recro rebrands to Societal CDMO
4 years ago
Manufacturing
Novo-partnered microcap biotech forced to halt PhIII enrollment in Russia and Ukraine as war continues
4 years ago
Merck? Check. Roche? Check. Now Bristol Myers Squibb wants AstraZeneca to pay for PD-L1 patents
4 years ago
Law
First page
Previous page
214
215
216
217
218
219
220
Next page
Last page